KM
VSTM icon

Kalos Management’s Verastem VSTM Stock Holding History

Kalos Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,729
Closed -$23K – 118
2022
Q2 		$23K Sell
1,729
-209
-11% -$3.33K 0.03% 132
2022
Q1 		$32K Buy
+1,938
New +$33.4K 0.02% 171
2021
Q4 		– Sell
-2,021
Closed -$70K – 286
2021
Q3 		$70K Sell
2,021
-83
-4% -$3.05K 0.02% 286
2021
Q2 		$88K Hold
2,104
– – 0.04% 258
2021
Q1 		$68K Hold
2,104
– – 0.02% 290
2020
Q4 		$53K Sell
2,104
-334
-14% -$6.71K 0.02% 248
2020
Q3 		$37K Hold
2,438
– – 0.02% 228
2020
Q2 		$50K Hold
2,438
– – 0.02% 211
2020
Q1 		$77K Hold
2,438
– – 0.03% 194
2019
Q4 		$39K Buy
2,438
+1,355
+125% +$19.5K 0.01% 201
2019
Q3 		$14K Sell
1,083
-1,355
-56% -$22K 0.01% 197
2019
Q2 		$44K Buy
+2,438
New +$55.2K 0.02% 188
2019
Q1 		– Sell
-2,438
Closed -$94K – 179
2018
Q4 		$94K Buy
2,438
+563
+30% +$34.4K 0.05% 183
2018
Q3 		$144K Buy
+1,875
New +$186K 0.08% 148

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Kalos Management's VSTM Position: Q3 2022 in Review

Kalos Management sold out of Verastem (VSTM) in Q3 2022, closing a stake of 1,729 shares — an estimated $23K sold.

Kalos Management first reported a position in VSTM in Q3 2018 and held it in 14 quarters. The position peaked at $144K in Q3 2018. 109 funds tracked by Wall St. Rank hold VSTM as of Q3 2022.

  • Kalos Management reported no remaining Verastem position as of Q3 2022 after selling out during the quarter.
  • Kalos Management sold 1,729 Verastem shares in Q3 2022, an estimated $23K.
  • Kalos Management first reported a position in Verastem in Q3 2018 and held it in 14 quarters.
  • Kalos Management's Verastem position peaked at $144K in Q3 2018.
  • 109 funds tracked by Wall St. Rank held Verastem as of Q3 2022.

Based on Kalos Management's 13F filing for Q3 2022, filed 21 Nov 2022.